Early lesion detection with 18F-DCFPyL PET/CT in 248 patients with biochemically recurrent prostate cancer.
M WondergemB H E JansenF M van der ZantT M van der SluisR J J KnolL W M van KalmthoutO S HoekstraR J A van MoorselaarD E Oprea-LagerA N VisPublished in: European journal of nuclear medicine and molecular imaging (2019)
18F-DCFPyL PET/CT offers early detection of lesions in patients with BCR, even at PSA levels <0.5 ng/ml. These results appear to be comparable to those reported for 68Ga-PSMA and 18F-PSMA-1007, with potentially increased detection efficacy compared to 68Ga-PSMA for patients with PSA <2.0.